News

Here are three durable businesses offering yields from 1.6% to 5.5%.

Eli Lilly (LLY) trades near $1,150, up about 52% over the past year, and is now worth more than a trillion dollars. At that size the easy read is that the big money has been made. But Lilly has barely started selling Foundayo, its oral obesity medicine, outside the United States. So how much is left? The scenario below starts from Lilly's own trailing numbers, but the growth, margin, and multiple it assumes are ours. It is not a forecast and not a price target.

Energy businesses quietly power the physical things we depend on, from cars and homes to e-commerce infrastructure. Still, their generally high capital requirements expose them to the ups and downs of commodity prices and economic cycles, and the industry’s six-month return of 6.3% has fallen short of the S&P 500’s 14% rise.

Accenture shares climbed nearly 9% in aftermarket trading. The technology consulting company announced a partnership with Anthropic Friday afternoon. The firm is establishing a team of "embedded evaluators" to work with Anthropic's internal teams in stress testing models, safeguards and alignment.

Eli Lilly stakes its trillion-dollar valuation on mid-stage data for a two-drug obesity combo, and the September 30 readout will reveal whether eloraTZP is a genuine franchise leap or an expensive gamble on incremental gains.

Most covered call ETFs hand you a fat monthly check while quietly draining your principal, but a small group of actively managed funds has cracked the formula to deliver both. The catch is that each one works for a completely different kind of investor.

Today, Sept. 18, 2026, Wells Fargo cut its rating and price target, citing weaker engagement and content concerns, prompting investors to watch margin trends.

The latest update on IREN trims the Fair Value estimate from US$80.93 to US$79.03, a relatively modest adjustment given the size of its AI ambitions. Analysts link this move to a mix of growing AI cloud contracts and ongoing questions around execution and supply build out through 2027, which both influence how comfortable they are with the stock’s valuation. As you read on, you will see how these shifting assumptions and fresh research calls are shaping the evolving IREN story and what it...

Advanced Micro Devices has ridden a powerful AI story in recent years, and the question now is whether the current share price is still grounded in the cash the business can realistically generate. For anyone watching AMD today, the focus has shifted from headline momentum to the harder question of what its cash flows are actually worth. Over the past 3 years, AMD has delivered a share price return of about 467%, which puts a lot of weight on the idea that future cash flows can justify such...

Centene (CNC) has moved back into focus after being highlighted for its earnings expectations, an attractive valuation profile, and exposure to growing ICHRA-driven individual coverage through its Ambetter Health Solutions business. Centene’s recent momentum has been hard to ignore, with a 90 day share price return of 9.96% feeding into a 60.60% year to date gain and a 1 year total shareholder return of 108.58%. This suggests investors are reassessing both its earnings profile and perceived...

By Exec-Edge Editorial Staff Sir Lynton Crosby has spent four decades reading public opinion for people who couldn’t afford to get it wrong — prime ministers, presidents, and the boards of some of the world’s largest companies. As Executive Chairman of CT Group, the research and strategy firm he co-founded, Crosby has built one of […] The post Sir Lynton Crosby, CT Group Executive Chairman, on the Case for Capitalism appeared first on ExecEdge.

A single ETF purchase made before most investors had ever heard the term changed what passive investing looks like today, but the original is no longer the obvious choice for everyone holding it.

American, United and Southwest are trimming schedules as fuel surges, while travelers already face fares nearly a quarter higher than a year ago

Key TakeawaysSix-Month Run: NVDA stock has climbed 20. 6% since mid-March, a 45.

The filing seeks CFTC approval for contracts giving US traders 24/5 leveraged exposure to individual stocks without ownership.

<p>Table below reflects daily flows on September 17, 2026 and asset totals as of that date.</p>

Find insight on Nutrien, Dyno Nobel, gold prices and more in the latest Market Talks covering Basic Materials.

Anthropic PBC is partnering with Accenture Plc, a management and technology consulting company, to test the safety of its advanced artificial intelligence models by embedding evaluators from the consulting firm directly within its operations.

NASA and Boeing are discussing 10 or more additional Starliner flights in the years ahead, the Wall Street Journal reported.

Costco just handed DoorDash a new same-day delivery deal, and Instacart shareholders took the hit, but the sell-off may have punished the wrong narrative entirely.

I'd buy Energy Transfer and Verizon stocks, and avoid Pfizer.

Rocket Lab (RKLB) has gained 9.5% over the last five trading days, while the S&P 500 added 0.6%. A week like that pulls money in. The stock is still about 55% below its 52-week high. The run is not the question. What matters for your money is what this stock does to your portfolio when the market moves, because it travels about four times as far as the index in both directions.

Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some may still have unproven business models, leaving them vulnerable to the ebbs and flows of the broader market.

The Standard & Poor's 500 index slipped 0.1% this week as the market digested a quarter-point rate i

Key TakeawaysCFO Ian Borden told investors on the Q2 2026 call that McDonald’s generated more than $4. 28 billion in restaurant margins and called franchisee financial health “still quite healthy,” citing ample borrowing capacity across the system.

Netflix shares have taken a hit lately. One group of experts sees the streaming giant’s stock falling even further.

A new price target has investors sitting up and taking note.

The trajectory of agentic commerce is splitting. Europe is prioritizing a regulatory-first architecture, while the United States remains stalled by a lack of federal guidance and unresolved liability questions. The same underlying technology is producing two distinct commercial realities. The European Regulatory Backbone Europe is utilizing the PSD3/PSR framework to define its deployment. The legislation, […]

The U.K.-based company didn’t say how many shares it would offer, or at what price, but intends to list shares on the New York Stock Exchange under the symbol NSCL.

The stock market showed choppy, mixed weekly action. But Robinhood, Sandisk, AMD and Moderna rallied into buy areas.